Safety and Immunogenicity of the RNA MCTI CIMATEC HDT Vaccine
Clinical trial NCT05542693 · UNKNOWN
Trial details
- NCT number
- NCT05542693
- Sponsor
- Azidus Brasil
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2023-03-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.